Therapy Areas: AIDS & HIV
Gilead Sciences Presents Survey Findings on PrEP Access and Utilization in the US During COVID-19 Shelter-in-Place Orders
8 July 2020 - - Data presented at the 23rd International AIDS Conference (AIDS 2020: Virtual) evaluated the impact of COVID-19 shelter-in-place orders (SIPOs) and PrEP utilisation on HIV preventi...
New Analyses Showing Additional Safety and Efficacy Data for Investigational Islatravir in Combination with Doravirine in Adults with HIV-1 Infection, US Merck Says
6 July 2020 - - US-based pharmaceutical company Merck (NYSE: MRK), known as MSD outside the United States and Canada, TODAY announced

New analyses from the Phase 2b trial (NCT03272347) e...
Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients
6 July 2020 - - The Drug Controller General of India (DCGI) has approved Dutch generic and specialty pharmaceutical company Mylan N.V.'s (NASDAQ: MYL) remdesivir 100 mg/vial for re...
Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate
19 June 2020 - - The first participants have been dosed in the Phase 1 first-in-human study evaluating Australia-based Clover Biopharmaceuticals' COVID-19 S-Trimer subunit vaccine candidate (SCB-...
Demant's revenues improve with easing of COVID-19 lockdown restrictions
18 June 2020 - Demant A/S (CPH:DEMANT), a hearing health care company within hearing aids, audiometric equipment and personal communication, on Wednesday reported that the hearing healthcare market co...
The FDA approves Tivicay and Tivicay PD drug to treat infants and children with HIV
15 June 2020 - Public health agency the US Food and Drug Administration reported on Friday that it has awarded approval for Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for sus...